These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24067671)

  • 1. HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies.
    Gardner K; Hall PA; Chinnery PF; Payne BA
    Toxicol Pathol; 2014 Jul; 42(5):811-22. PubMed ID: 24067671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
    Hung KM; Chen PC; Hsieh HC; Calkins MJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):406-413. PubMed ID: 27840304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.
    Feeney ER; Mallon PW
    Curr Pharm Des; 2010 Oct; 16(30):3339-51. PubMed ID: 20687890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.
    Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S
    AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
    Maagaard A; Kvale D
    J Antimicrob Chemother; 2009 Nov; 64(5):901-9. PubMed ID: 19740910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.
    Poirier MC; Gibbons AT; Rugeles MT; Andre-Schmutz I; Blanche S
    Curr Opin Pediatr; 2015 Apr; 27(2):233-9. PubMed ID: 25635584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
    Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
    Moyle G
    Clin Ther; 2000 Aug; 22(8):911-36; discussion 898. PubMed ID: 10972629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA mutations in ageing and disease: implications for HIV?
    Payne BA; Gardner K; Chinnery PF
    Antivir Ther; 2015; 20(2):109-20. PubMed ID: 25032944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions.
    Lewis W
    Antiviral Res; 2003 May; 58(3):189-97. PubMed ID: 12767466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.
    Jones SP; Qazi N; Morelese J; Lebrecht D; Sutinen J; Yki-Jărvinen H; Back DJ; Pirmohamed M; Gazzard BG; Walker UA; Moyle GJ
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):565-72. PubMed ID: 16284533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
    Côté HC
    Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity.
    Höschele D
    Toxicol In Vitro; 2006 Aug; 20(5):535-46. PubMed ID: 16406476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside reverse transcriptase inhibitors induced hepatocellular mitochondrial DNA lesions and compensatory enhancement of mitochondrial function and DNA repair.
    Liang Q; Zeng J; Wu J; Qiao L; Chen Q; Chen D; Zhang Y
    Int J Antimicrob Agents; 2018 Mar; 51(3):385-392. PubMed ID: 28843815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.
    Liu K; Sun Y; Liu D; Yin J; Qiao L; Shi Y; Dong Y; Li N; Zhang F; Chen D
    PLoS One; 2013; 8(2):e57223. PubMed ID: 23468942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the toxicity of HIV medications.
    Margolis AM; Heverling H; Pham PA; Stolbach A
    J Med Toxicol; 2014 Mar; 10(1):26-39. PubMed ID: 23963694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.
    Ciccosanti F; Corazzari M; Soldani F; Matarrese P; Pagliarini V; Iadevaia V; Tinari A; Zaccarelli M; Perfettini JL; Malorni W; Kroemer G; Antinori A; Fimia GM; Piacentini M
    Antivir Ther; 2010; 15(3):377-90. PubMed ID: 20516557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.